A collection of news and information related to Pradaxa (drug) published by this site and its partners.
Displaying items 1-5 of 5 » View kspr.com items only
The Hartford CourantAt Boehringer Ingelheim Pharmaceuticals, the second-largest drug company in Connecticut, the local workforce increased by more than 40 percent over the last 10 years, at the same time its employee numbers worldwide grew by 35 percent. A company that...
Ever since the drug warfarin was discovered to be a highly effective anti-clotting agent as well as a good rat poison in the early 1950s, it has been the frontline weapon in preventing stroke among those with atrial fibrillation. But its growing use has...
ReutersINGELHEIM, Germany, April 24 (Reuters) - Boehringer Ingelheim said its anti-blood-clotting drug Pradaxa reached blockbuster status in 2012, helping the world's largest unlisted drugmaker to an 11.5 percent rise in sales for last year. Sales of the pill,...
ReutersLOS ANGELES (Reuters) - The cost of treating heart disease has become a key factor in decisions by U.S. cardiologists grappling with the nation's No. 1 killer. Record prices for drugs and devices, reduced reimbursement by insurance plans and the...
May 15, 2013 |Story| Hartford Courant
Apr 29, 2013 |Story| Los Angeles Times
Apr 24, 2013 |Story| Reuters
Nov 12, 2012 |Story| Reuters
Jan 10, 2012 |Story| Los Angeles Times
Original site for Pradaxa (drug) topic gallery.